Lilly's Covid-19 mAb no longer authorized due to Omicron subvariants, FDA says

Lilly's Covid-19 mAb no longer authorized due to Omicron subvariants, FDA says

Submitted by admin on November 30, 2022 - 8:04pm
Source: 
Endpoints
News Tags: 
Eli Lilly
FDA
COVID-19
Omicron
bebtelovimab
monoclonal antibodies
Headline: 
Lilly's Covid-19 mAb no longer authorized due to Omicron subvariants, FDA says
snippet: 

The FDA on Wednesday announced that Eli Lilly’s Covid-19 drug bebtelovimab is no longer authorized to treat Covid-19 because of the rising numbers of two new subvariants that the drug does not work against.

Do Not Allow Advertisers to Use My Personal information